Charles River Laboratories International Inc (CRL.N)
CRL.N on New York Stock Exchange
44.54USD
24 May 2013
44.54USD
24 May 2013
Price Change (% chg)
$0.19 (+0.43%)
$0.19 (+0.43%)
Prev Close
$44.35
$44.35
Open
$44.17
$44.17
Day's High
$44.54
$44.54
Day's Low
$43.68
$43.68
Volume
17,938
17,938
Avg. Vol
179,521
179,521
52-wk High
$46.90
$46.90
52-wk Low
$31.48
$31.48
CRL.N
About
Charles River Laboratories International, Inc. is a global provider of solutions, which accelerate the early-stage drug discovery and development process. The focus of its business is in vivo biology; its portfolio includes research models and services required to enable in vivo drug discovery and development. The Company... (more)
Overall
| Beta: | 1.15 |
| Market Cap (Mil.): | $2,174.45 |
| Shares Outstanding (Mil.): | 49.03 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
Competitors
| Price | Change | |
|---|---|---|
| Life Technologies Corp. (LIFE.OQ) | $74.00 | +0.06 |
| Bioanalytical Systems, Inc. (BASI.OQ) | $1.56 | -0.08 |
| Vertex Pharmaceuticals Incorporated (VRTX.OQ) | $78.17 | -0.31 |
| Crucell N.V. (CRCL.AS) | -- | -- |
| Onyx Pharmaceuticals, Inc. (ONXX.OQ) | $95.12 | -1.08 |
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
